The costs and expected health impact of maintaining the support to these recipients have been projected until 2020. The projections include total program costs met by domestic contributions as well as external contributions.
This study estimates the economic returns that Global Fund-supported ARV therapy services and their associated health benefits can generate over the 11-year period 2011 to 2020. The presented new model quantifies economic returns by linking Global Fund grant delivery results with projections of the future costs of ARV therapy programs and of corresponding gains in patient survival and the economic value of life-years gained.
This report is based on a meeting held 3-4 December 2009 in Amsterdam, the Netherlands. The gathering, a “Strategy Meeting on Resource Mobilization for the Global Fund to Fight AIDS, Tuberculosis and Malaria”, was co-organised by a locally based non-governmental organization (NGO), International Civil Society Support (ICSS), and the Global Fund.
The meeting was timed to coincide with the beginning of the Global Fund’s 2010 resource mobilization and replenishment process.